Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-to-Participate-in-the-Jefferies-London-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-Reports-Third-Quarter-2024-Results/default.aspx
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Once-Weekly-Apraglutide-Showed-Consistent-Treatment-Effect-Across-Baseline-Demographics-and-Disease-Characteristics-in-Adults-with-Short-Bowel-Syndrome-with-Intestinal-Failure-SBS-IF-According-to-New-STARS-Phase-III-Data-from-Ironwood-at-ACG-2024/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2024-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-to-Participate-in-the-2024-Wells-Fargo-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-Reports-Second-Quarter-2024-Results/default.aspx
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-to-Host-Second-Quarter-2024-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-to-Participate-in-the-Jefferies-Global-Healthcare-Conference/default.aspx
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Late-Breaker-Oral-Presentation-at-Digestive-Disease-Week-Reinforces-Potential-of-Once-Weekly-Apraglutide-for-Adults-with-Short-Bowel-Syndrome-with-Intestinal-Failure-SBS-IF/default.aspx
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Pharmaceuticals-Reports-First-Quarter-2024-Results/default.aspx
